Wie hoch ist der Preis für Pharmanutra S.p.A. (PHN)

Preis für Pharmanutra S.p.A. (PHN) ist $97.03

Wie hoch ist die Marktkapitalisierung für Pharmanutra S.p.A. (PHN)

Marktkapitalisierung für Pharmanutra S.p.A. (PHN) ist $929.06M

Pharmanutra S.p.A. (PHN) Umsatz

Pharmanutra S.p.A. functions as a pharmaceutical and nutraceutical enterprise, focusing on the research, development, design, and marketing of nutritional supplements and medical devices. Its market reach extends across Italy, other parts of Europe, the Middle East, the Far East, and globally. Moreover, the company manufactures and promotes pharmaceuticals, medical devices, over-the-counter (OTC) items, and nutraceuticals specifically for the pediatric population. Furthermore, Pharmanutra is a producer and supplier of raw materials and active ingredients to the food, pharmaceutical, and dietary supplement industries. Its diverse product portfolio features prominent brands like the SiderAL series (including SiderAL Forte, SiderAL Folic, Cardio SiderAL, SiderAL Med), the Cetilar range (Cetilar Crema, Cetilar Patch, Tape), along with ApportAL, UltraMag, Gestalys DHA, Novomega, Bonecal, and DiKappa 2. These products are distributed and sold through a network comprising sales representatives, wholesalers, pharmacies, and para-pharmacies. Established in 2003, the company's base of operations is in Pisa, Italy.

Jahr	Umsatz	ändert
Nicht genügend Daten für die angegebenen Daten.

Jahr

Umsatz

ändert

Nicht genügend Daten für die angegebenen Daten.

Unternehmen	Umsatz	Umsatzunterschied	Land
MERCK Kommanditgesellschaft auf Aktien MER.SW	-	-	DE
Merck KGaA MRK.DE	-	-	DE
Takeda Pharmaceutical Company Limited 4502.T	-	-	JP
Galderma Group AG GALD.SW	-	-	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	$6.61B	-	IN

Unternehmen

Umsatz

Umsatzunterschied

Land